OmniAb, Inc. (OABI) — Stock Score Summary

OmniAb, Inc. (OABI) has a MoatMap StockRank of 61/100 based on Quality (39/100), Value (43/100), and Momentum (64/100) factor scores. The current signal is HOLD. OmniAb is an antibody discovery platform. While conceptually interesting as an asset-light royalty model, it currently lacks the scale, high ROIC, and established cash flows of a high-conviction compounder, failing our quality filters.

OmniAb, Inc. is a biotechnology company focused on providing a comprehensive suite of proprietary antibody discovery technologies, including genetically engineered animals and in vitro display systems. These platforms enable its partners to discover and develop novel therapeutic antibodies for a wide range of diseases. OmniAb holds a strong niche market position as a technology licensor, critical to the R&D efforts of numerous pharmaceutical and biotech companies globally.

Key Financial Metrics

Price$2.40
Market Cap$394M
P/E (Forward)-8.25
Price/Book1.47
Return on Equity-20.3%
Return on Invested Capital-24.2%
Debt/Equity7.49
Gross Margin98.9%
Operating Margin-54.3%
Revenue Growth247.3%
Free Cash Flow$-3M

OmniAb, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is OmniAb, Inc.’s (OABI) StockRank?
MoatMap’s StockRank for OmniAb, Inc. (OABI) is 61/100, with a Hold signal. It is a composite of Quality (39), Value (43), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does OmniAb, Inc. have an economic moat?
OmniAb, Inc. (OABI) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is OmniAb, Inc. a buy, hold, or sell?
MoatMap’s current signal for OmniAb, Inc. (OABI) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is OmniAb, Inc. in?
OmniAb, Inc. (OABI) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksOABI deep dive reportAI ChampionsHow we score stocksSense-check another stock